Dementia Prevention
Why Blood Testing Could
Help Prevent Early
Dementia
Dementia doesn't arrive without warning — it begins silently, up to 20 years before the first symptom appears. Many of its most powerful risk factors show up clearly in a blood test. The question isn't whether you should check. It's how soon.
The Window of Opportunity
Dementia Has a Long Silent Phase. That's Where the Opportunity Lives.
Most people think of dementia as something that happens to older people — a diagnosis that arrives in your 70s or 80s with no warning. But the biological story starts much earlier. In Alzheimer's disease, the most common form, proteins begin accumulating in the brain up to two decades before a person notices any memory or thinking problems.
That two-decade window isn't just a frightening fact. It's an extraordinary opportunity. Because during that silent phase, the risk factors driving those changes are measurable, modifiable, and — in many cases — directly detectable through blood testing.
The 2024 Lancet Commission on Dementia Prevention concluded that around 45% of dementia cases globally could be prevented or significantly delayed by addressing 14 modifiable risk factors. Several of those factors show up clearly in a standard blood panel. You don't need to wait for symptoms. You don't need a specialist referral. You just need to know your numbers.
The best time to act on dementia risk isn't when you notice something is wrong. It's 20 years before that — when a blood test can show you what to change.
How It Develops
The Silent 20-Year Timeline Nobody Talks About
Understanding how dementia develops helps explain why early blood testing is so powerful — and why waiting for symptoms means you've already missed the most important window.
20+ years before symptoms
Amyloid proteins begin accumulating silently in the brain. No symptoms whatsoever. But risk factors — high LDL cholesterol, insulin resistance, elevated homocysteine, vitamin D deficiency, inflammation — are measurable in blood and actively contributing to the process. This is the most powerful window for prevention.
10–15 years before symptoms
Tau tangles begin forming. Brain volume starts to decline in subtle ways. Blood biomarkers like p-tau217 may now be detectable. Lifestyle and metabolic risk factors, if still unaddressed, are accelerating the process. Still no noticeable symptoms for most people.
5 years before symptoms
Mild cognitive impairment (MCI) may begin — subtle changes in memory, word-finding, or processing speed that are noticeable to the person but not yet clinically significant. Blood biomarkers are increasingly reliable at this stage. Intervention is still meaningful.
Symptoms appear — diagnosis begins
Noticeable memory problems, confusion, and language difficulties prompt a GP visit. Average wait from referral to diagnosis in the UK is now 17.7 weeks — up from 13 weeks in 2019. By this point, significant neurological damage has already occurred. Treatment options are limited. The prevention window has closed.
The Blood Tests That Matter Most
What to Check — and What Each One Actually Does to Your Brain
These are the blood markers with the strongest, most evidence-backed links to dementia risk — the ones that are actionable right now, through private testing, years before any specialist involvement.
Blood-testable risk factors — estimated contribution to dementia cases
Source: 2024 Lancet Commission on Dementia Prevention. All of these factors are detectable via private blood testing — and most are meaningfully modifiable through lifestyle and targeted supplementation.
The Homocysteine Breakthrough
The Brain Health Marker Most People Have Never Tested — But Should
Of all the blood markers linked to dementia prevention, homocysteine has some of the most compelling — and most under-appreciated — evidence behind it. Yet it's almost never included in standard NHS panels, and most people have never had it tested.
The Oxford VITACOG Trial — a landmark finding
In this double-blind clinical trial, participants with mild cognitive impairment and elevated homocysteine were given high-dose B vitamins (B12, B6, and folic acid). After two years, those taking the vitamins showed up to 53% less brain atrophy than those on placebo — and significantly less cognitive decline. The effect was strongest in those with the highest baseline homocysteine. This is one of the most compelling nutritional interventions ever demonstrated for brain health — and it starts with a simple blood test to know your level.
Homocysteine rises when B12, B6, and folate are deficient. In the UK, these deficiencies are common — particularly in older adults, those following plant-based diets, and anyone on the contraceptive pill or long-term medications like metformin. The optimal homocysteine level is below 10 µmol/L. Many people are significantly above this without knowing.
The intervention is simple, safe, and inexpensive: B vitamin supplementation tailored to your levels. But you can only act on it if you know your number.
The Emerging Science
The Blood Test That Could Detect Alzheimer's Before Symptoms Begin
Beyond modifiable risk markers, a genuinely revolutionary development is now underway in the UK: a blood test that can detect the biological hallmarks of Alzheimer's disease itself — years before symptoms appear.
The ADAPT Trial — launched August 2025
In August 2025, the first participants were recruited to the ADAPT trial — a landmark UK clinical trial examining whether a blood test (specifically p-tau217, which reflects amyloid and tau accumulation in the brain) can help diagnose Alzheimer's earlier and more accurately. The trial is running across 19+ NHS specialist centres, funded by Alzheimer's Society, Alzheimer's Research UK, and the People's Postcode Lottery as part of the £5 million Blood Biomarker Challenge. The goal: to bring dementia blood testing into routine NHS care within the next few years — transforming diagnosis from a lengthy, invasive, and often late-stage process into something as accessible as a cholesterol check.
Current diagnostic methods vs emerging blood biomarkers
Source: ADAPT trial / NHS National Audit of Dementia 2024 / Alzheimer's Society Blood Biomarker Challenge 2025. The average wait from referral to diagnosis has increased from 13 weeks in 2019 to 17.7 weeks — with some waiting up to 2 years.
What You Can Do Right Now
Don't Wait for the NHS to Catch Up. Start Your Prevention Today.
The ADAPT trial is exciting news — but it will be several years before blood biomarker testing reaches routine NHS care. The good news is that you don't need to wait. The modifiable risk markers — the ones that account for nearly half of all dementia cases — are available through private blood testing right now.
Test your homocysteine — it should be first on your list
This is the most overlooked brain health marker with some of the strongest evidence behind it. Aim for below 10 µmol/L. If it's elevated, high-dose B12, B6, and folate can bring it down — with real, measurable impact on brain health over time.
Know your cholesterol — especially your LDL
High LDL is now the single largest newly identified modifiable dementia risk factor. It causes no symptoms. A full lipid panel takes moments and could give you 20+ years of cardiovascular and brain protection if you act on the results in midlife.
Optimise your vitamin D
UK deficiency is near-universal in winter. Supplementing to maintain levels of 100–150 nmol/L supports brain health, immune function, and mood. You cannot know where you are without testing — and supplementing without a baseline means you're guessing.
Check your blood sugar with HbA1c
Insulin resistance precedes type 2 diabetes by years — and it's directly harmful to the brain. HbA1c catches it early, when dietary and lifestyle changes can reverse the trajectory before any formal diagnosis would be made.
Add inflammation (hs-CRP) and thyroid (TSH)
These two markers round out a comprehensive brain health picture. Chronic inflammation is a key driver of neurodegeneration. Thyroid dysfunction directly impairs cognitive function and is commonly undiagnosed. Together with the markers above, you have a genuinely powerful prevention panel.
Test annually — trends matter more than snapshots
Dementia risk is cumulative over decades. A single test tells you where you are. Annual testing tells you whether your lifestyle, diet, and supplementation are actually working. The earlier you start building that data, the more powerful it becomes.
The brain changes that lead to dementia begin 20 years before symptoms. The best time to act was 20 years ago. The second best time is today.
Start Protecting Your Brain Today
Private blood testing gives you the data to understand and address your dementia risk factors — decades before they become problems. At Boost & Glow, we can help you take the right first step.
Explore Boost & Glow → Ask Us a Question →This blog is for informational purposes only and does not constitute medical advice. Blood testing for dementia risk markers is not a diagnostic test for dementia. If you have concerns about memory or cognitive function, please speak to your GP. Always consult a qualified healthcare professional before making changes to your health routine based on test results.
0 comments